Contact us at: jstroll1@optonline.net

Established 1968

Don't get hysterical, call our Medical- Medi-Temps USA!
Menu
  • HOME
    • About US
    • MONSTER Jobs
      • MONSTER Job Board Widget
      • MONSTER Job Search Widget
      • Close
    • Close
  • JOBS MAP
  • How it works
    • Ad Prices
    • RESUME Pricing
    • JOB Pricing
    • Close
  • Candidates
  • Post A Job
  • Companies
    • Company Finance
    • Company Network
      • Company Profiles
      • Close
    • Resume MAP
      • Manage Jobs
      • Close
    • Pricing Plans
      • Ad Prices
      • RESUME Pricing
      • JOB Pricing
      • Candidates
      • Close
    • Close
  • Sponsors
    • Featured Sponsors
    • Ad Prices
    • Shaklee History
      • Shaklee Home page
      • Shaklee Life Plan
      • Close
    • Close
  • News
    • FDA.gov
      • Animal & Veterinary by FDA
      • Children’s Health by FDA
      • Cosmetics by FDA
      • Dietary Supplements by FDA
      • Drugs by FDA
      • Food by FDA
      • Close
    • What’s New Related to Drugs
    • Biosimilars by FDA
    • Biotech Overview
      • Biotechnology News
      • Biotech Company Index
      • Close
    • Drug Delivery
      • Drug Delivery News
      • Drug Delivery Company Index
      • Close
    • Drug Manufacturers – Major
      • Drug Manufacturers Major NEWS
      • DRUG MANUFACTURERS – MAJOR Company Index
      • Close
    • Drug Manufacturers – Other
      • Drug Manufacturers OTHER NEWS
      • Drug Manufacturers OTHER Company Index
      • Close
    • Find Information about a Drug by FDA
    • Health Videos by NIH
    • Johns Hopkins
    • Mayo Clinic
    • Medicines and You: A Guide for Older Adults by FDA
    • Medline News
    • Close
  • Post a Resume
  • Login
    • Sign Up
    • Close
Written by Medi-Temps USA
January 23, 2015

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)

Aprea’s ovarian cancer drug candidate APR-246 gets European orphan drug status

Swedish biotech company Aprea has secured orphan drug designation from the European Medicines Agency (EMA) for its anti-cancer agent APR-246 to treat ovarian cancer.

Related

Category One, Showcase, status, Uncategorized, What's Hot

Recent Posts

  • FDA Pet Health
  • FDA Blog
  • What's New: Animal & Veterinary
  • What's New: Vaccines, Blood & Biologics RSS Feed
  • What's New: Foods RSS Feed

Categorires

Got a question?

We're here to help. Check out our FAQs, send us an email or call us at 1 203-227-3688

“Just a Temp, Just in Time!”

Job Searching Just Got Easy.

Medi-Temps USA to find
* the vacation/sick relief;
* special projects where an expert is required or
*find an advisor to the team!

"Just a Temp, Just in Time!"

Headquarters

Medi-Temps USA
Bank of America building
Second Floor
980 Post Road East,
Westport, CT 06880
1 203-208-9940

  • Contact
  • Privacy Policy
  • Terms and Conditions
  • About US
© 2019 Medi-Temps USA — All Rights Reserved
Back to Top
This website uses cookies to improve your experience. By continuing to use this website, you agree to the use of cookies.Accept Reject Privacy Policy
Privacy & Cookies Policy

Necessary Always Enabled

Non-necessary